Works about BEVACIZUMAB

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II).

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 2, p. 303, doi. 10.1007/s11060-019-03227-7
    By:
    • Hainsworth, John D.;
    • Becker, Kevin P.;
    • Mekhail, Tarek;
    • Chowdhary, Sajeel A.;
    • Eakle, Janice Faulkner;
    • Wright, David;
    • Langdon, Robert M.;
    • Yost, Kathleen J.;
    • Padula, Gilbert Darin Anthony;
    • West-Osterfield, Kimberly;
    • Scarberry, Meredith;
    • Shaifer, Candice A.;
    • Shastry, Mythili;
    • Burris III, Howard A.;
    • Shih, Kent
    Publication type:
    Article
    19
    20

    pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 587, doi. 10.1007/s11060-019-03132-z
    By:
    • Yao, Jingwen;
    • Tan, Caleb Hock Pang;
    • Schlossman, Jacob;
    • Chakhoyan, Ararat;
    • Raymond, Catalina;
    • Pope, Whitney B.;
    • Salamon, Noriko;
    • Lai, Albert;
    • Ji, Matthew;
    • Nghiemphu, Phioanh L.;
    • Liau, Linda M.;
    • Cloughesy, Timothy F.;
    • Ellingson, Benjamin M.
    Publication type:
    Article
    21
    22
    23

    Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

    Published in:
    Journal of Neuro-Oncology, 2018, v. 140, n. 3, p. 623, doi. 10.1007/s11060-018-2989-z
    By:
    • Palmer, Joshua D.;
    • Bhamidipati, Deepak;
    • Song, Andrew;
    • Eldredge-Hindy, Harriet B.;
    • Siglin, Joshua;
    • Dan, Tu D.;
    • Champ, Colin E.;
    • Zhang, Isabella;
    • Bar-Ad, Voichita;
    • Kim, Lyndon;
    • Glass, Jon;
    • Evans, James J.;
    • Andrews, David W.;
    • Werner-Wasik, Maria;
    • Shi, Wenyin
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Spinal ependymomas in NF2: a surgical disease?

    Published in:
    Journal of Neuro-Oncology, 2018, v. 136, n. 3, p. 605, doi. 10.1007/s11060-017-2690-7
    By:
    • Kalamarides, M.;
    • Essayed, W.;
    • Lejeune, J. P.;
    • Aboukais, R.;
    • Sterkers, O.;
    • Bernardeschi, D.;
    • Peyre, M.;
    • Lloyd, S. K.;
    • Freeman, S.;
    • Hammerbeck-Ward, C.;
    • Kellett, M.;
    • Rutherford, S. A.;
    • Evans, D. G.;
    • Pathmanaban, O.;
    • King, A. T.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 131, n. 1, p. 117, doi. 10.1007/s11060-016-2276-9
    By:
    • Morris, Katrina;
    • Golding, John;
    • Blesing, Claire;
    • Evans, D.;
    • Ferner, Rosalie;
    • Foweraker, Karen;
    • Halliday, Dorothy;
    • Jena, Raj;
    • McBain, Catherine;
    • McCabe, Martin;
    • Swampillai, Angela;
    • Warner, Nicola;
    • Wilson, Shaun;
    • Parry, Allyson;
    • Afridi, Shazia
    Publication type:
    Article
    50